Chief Executive's biography
Professor Jackie Hunter CBE
Professor Jackie Hunter joined BBSRC as Chief Executive in October 2013. Jackie has over thirty years of experience in the bioscience research sector, working across academia and industry and playing a key role in innovative collaborations and partnerships. She holds a personal chair from St George's Hospital Medical School, which was awarded in recognition of her contribution to bioscience research.
Jackie Hunter gained her first degree in Physiology and Psychology at the University of London followed by her PhD which was carried out at the Zoological Society of London. She undertook a Wellcome Trust post-doctoral research fellowship at St George's Hospital Medical School before joining the pharmaceutical industry in 1983.
Her industrial was primarily spent in neuroscience research cumulating in leading global neurology and gastrointestinal drug discovery and early clinical development for GlaxoSmithKline (GSK). Subsequently Jackie spent several years developing and leading GSK's external science engagement strategy. In this role she played a central part in fostering effective and innovative collaborations and partnerships between university and institute research groups and the company as well as stimulating interactions between academia and the industry more generally as Chair of the EFPIA Research Directors Group.
On leaving GSK she founded OI Pharma Partners in 2010 to support the life science sector in harnessing the power of open innovation. Open innovation allows public and private organisations to use a range of collaborative models to find the best ways to bring ideas to fruition. Jackie was awarded a CBE in the Queen's Birthday Honours list for Services to the Pharmaceutical Industry and also the Women of Achievement in Science, Engineering and Technology (SET) award in the category SET Discovery, Innovation and Entrepreneurship in 2010.
Jackie is a current member of the Council of the University of Hertfordshire and previously served on the Council of Royal Holloway University of London as well as the governing body of the Babraham Institute. From 2004 Jackie was a member of BBSRC Council and had previously been a member of the BBSRC Strategy Board as well as serving on numerous panels and committees for the BBSRC and other funders. She is a Fellow of the British Pharmaceutical Society and was elected a Fellow of the Academy of Medical Sciences in 2014.